phenyl acetate has been researched along with thapsigargin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dupont, Y; Gerwert, K; Troullier, A | 1 |
Chen, WR; Shepherd, GM; Xiong, W | 1 |
Choi, JI; Jeong, SW; Yoon, MH | 1 |
Bristulf, J; Haeggström, JZ; Karlsson, U; Owman, C; Sabirsh, A | 1 |
Foreman, RC; Pivovarov, AS; Walker, RJ | 1 |
Bates, G; Di Capite, J; Nelson, C; Parekh, AB | 1 |
Brummond, KM; Burrows, LC; Geib, SJ; Jesikiewicz, LT; Liu, P; Lu, G | 1 |
7 other study(ies) available for phenyl acetate and thapsigargin
Article | Year |
---|---|
A time-resolved Fourier transformed infrared difference spectroscopy study of the sarcoplasmic reticulum Ca(2+)-ATPase: kinetics of the high-affinity calcium binding at low temperature.
Topics: Acetates; Animals; Binding Sites; Calcium; Calcium-Transporting ATPases; Chelating Agents; Ethylenediamines; Kinetics; Muscle, Skeletal; Protein Conformation; Rabbits; Sarcoplasmic Reticulum; Spectroscopy, Fourier Transform Infrared; Thapsigargin; Time Factors | 1996 |
Analysis of relations between NMDA receptors and GABA release at olfactory bulb reciprocal synapses.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Acetates; Animals; Cadmium; Calcium; Calcium Channels; Chelating Agents; Dendrites; Enzyme Inhibitors; Ethylenediamines; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Feedback; gamma-Aminobutyric Acid; Membrane Potentials; Neural Inhibition; Neurotransmitter Agents; Nickel; Olfactory Bulb; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Synapses; Thapsigargin | 2000 |
Spinal gabapentin and antinociception: mechanisms of action.
Topics: Acetates; Adrenergic alpha-Antagonists; Adrenergic Antagonists; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amines; Analgesics; Animals; Atropine; Cyclohexanecarboxylic Acids; Dihydroergocristine; Enzyme Inhibitors; Excitatory Amino Acid Agonists; GABA Antagonists; Gabapentin; gamma-Aminobutyric Acid; Injections, Spinal; Leucine; Male; Mecamylamine; Muscarinic Antagonists; N-Methylaspartate; Naloxone; Narcotic Antagonists; Nicotinic Antagonists; Pain Measurement; Quinazolines; Rats; Rats, Sprague-Dawley; Serine; Spinal Cord; Thapsigargin; Triazoles | 2003 |
Non-specific effects of leukotriene synthesis inhibitors on HeLa cell physiology.
Topics: Acetates; Acrylates; Arachidonate 5-Lipoxygenase; Arachidonic Acids; Benzoates; Calcium Signaling; HeLa Cells; Humans; Indoles; Ionomycin; Leukocytes; Leukotriene Antagonists; Leukotriene B4; Organophosphonates; Polymerase Chain Reaction; Receptors, Leukotriene B4; Thapsigargin; Thiophenes; Transfection | 2005 |
Involvement of Na,K-pump in SEPYLRFamide-mediated reduction of cholinosensitivity in Helix neurons.
Topics: Acetates; Acetylcholine; Animals; Brain; Calcium; Enzyme Inhibitors; Guanosine 5'-O-(3-Thiotriphosphate); Helix, Snails; Indoles; Membrane Potentials; Neurons; Neuropeptides; Ouabain; Sodium Chloride; Sodium-Potassium-Exchanging ATPase; Thapsigargin | 2007 |
Targeting Ca2+ release-activated Ca2+ channel channels and leukotriene receptors provides a novel combination strategy for treating nasal polyposis.
Topics: Acetates; Arachidonate 5-Lipoxygenase; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Cyclopropanes; Humans; Hydroxyurea; Leukotriene Antagonists; Leukotriene C4; Mast Cells; Nasal Polyps; Quinolines; Receptors, Leukotriene; Sulfides; Thapsigargin | 2009 |
Computationally Guided Catalyst Design in the Type I Dynamic Kinetic Asymmetric Pauson-Khand Reaction of Allenyl Acetates.
Topics: Acetates; Alkenes; Catalysis; Cyclopentanes; Kinetics; Ligands; Reproducibility of Results; Rhodamines; Stereoisomerism; Thapsigargin | 2017 |